This report shows how dangerous and under-reported the negative affects of Big Pharma drugs are.
QuarterWatch? is an ISMP surveillance program that monitors all serious, disabling, and fatal adverse drug events (ADEs) reported to the US Food and Drug Administration (FDA) by drug manufacturers and by the public through its MedWatchreporting program. The goal of QuarterWatch? is to improve patient safety through the identification of signals that may represent important drug safety issues. The term signal means evidence we judge to be substantial enough to warrant publication but which usually requires further investigation to determine its frequency of occurrence and establish a causal relationship to the suspect drug. The latest QuarterWatch? combines data from the four quarters of 2011 to examine annual reporting totals, trends, and ADE signals.
Read the full report here:
http://www.ismp.org/newsletters/ambulatory/issues/community201206.pdf
